Shutting Down Domain Names Tied to Illegal Online Pharmacies Can Protect Patients, NABP Report Finds

Posted by

Person using laptop with data and technology icons displaying across the image

The National Association of Boards of Pharmacy® (NABP®) has released a new report, Disrupting Illegal Online Pharmacies: Lock-and-Suspend as a Tool to Protect Patients, which explores the process and impact of locking and suspending domain names associated with websites that illegally sell prescription medications online. The report explains how lock-and-suspend directly impacts patient safety, concluding […]

Read More ›

NABP Enters Final Development Phase of DSCSA Interoperability Network

Posted by

Integrate Technology

New Network Provides Regulators, Industry With Tool to Further Protect Drug Supply Chain The National Association of Boards of Pharmacy® (NABP®) announced today that it is entering the final phase of development for its new network to facilitate supply chain interoperability. The network will provide a means for state regulators and trading partners to investigate […]

Read More ›

NABP Specialty Pharmacy Accreditation Earns Optum Rx Network Recognition  

Posted by

Icon of Lightbulb

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that its Specialty Pharmacy Accreditation has earned recognition from Optum Rx’s Specialty Pharmacy Network. This recognition deems NABP as an approved accrediting organization for pharmacies seeking specialty accreditation to qualify for participation in the Optum Rx Specialty Pharmacy Network.   NABP’s Specialty Pharmacy Accreditation […]

Read More ›

NABP Joins Other Regulatory Associations In Launching Opioid Regulatory Collaborative

Posted by

Icon of newspaper

NABP and three other state board associations, have launched the Opioid Regulatory Collaborative (ORC). The ORC will bring together senior leaders from NABP, the American Association of Dental Boards, the Federation of State Medical Boards, and the National Council of State Boards of Nursing to share resources and strategies to slow opioid substance use disorder […]

Read More ›

NABP Launches Compounding Pharmacy Information-Sharing Project With FDA

Posted by

Person using laptop with data and technology icons displaying across the image

In June 2020, the National Association of Boards of Pharmacy (NABP) began to further develop a system to gather and share compounding pharmacy information as part of a three-year pilot project with Food and Drug Administration (FDA). Funded by FDA, this project builds upon the existing NABP e-Profile system with the addition of data fields and functionality […]

Read More ›

NABP Urges Passage of the Mainstreaming Addiction Treatment Act by 117th Congress

Posted by

Icon of newspaper

The National Association of Boards of Pharmacy® (NABP®) continues its call for the passage of the Mainstreaming Addiction Treatment Act to remove barriers that prevent those with opioid use disorder (OUD) from accessing vital, lifesaving addiction treatment. This bipartisan bill was introduced today by Representatives Paul Tonko (D-NY), Michael Turner (R-OH), Antonio Delgado (D-NY), Anthony Gonzalez […]

Read More ›

New NABP Report Explores How Pharmacists Can Safeguard Patients From Risky Dietary Supplements

Posted by

Miscellaneous colorful pills in packaging

In the National Association of Boards of Pharmacy® (NABP®) January 2021 Rogue Rx Activity Report, the association focuses on the risk of tainted dietary supplements to consumers. The report, titled Risky Dietary Supplements: How Pharmacists Can Help Protect Patients, explores adulterated dietary supplements that enter the marketplace and how pharmacists are well-positioned to provide consumers with information […]

Read More ›

Don’t be guilty of scheduling dose #2 of COVID-19 vaccine too early!

Posted by

Icon of newspaper

Written by: Immunization Action Coalition The recommended dosing intervals for the 2-dose mRNA COVID-19 vaccines are 21 days for Pfizer-BioNTech’s vaccine and 28 days for Moderna’s. Some vaccination clinics are scheduling dose #2 appointments up to 4 days early (i.e., at 17 days) for Pfizer-BioNTech’s vaccine, and as early as 24 days for Moderna’s. COVID-19 […]

Read More ›

NABP Receives BBB Torch Award for Marketplace Ethics

Posted by

Icon of pen and paper

The National Association of Boards of Pharmacy® (NABP®) received the Better Business Bureau (BBB) of Chicago and Northern Illinois’s Torch Award for Marketplace Ethics on December 10, 2020. “The Torch Award is the most prestigious award the BBB can present to a business,” said Steve J. Bernas, president & CEO of the Better Business Bureau serving Chicago […]

Read More ›

NABP Urges Congressional Leaders to Continue Supporting Federal Programs to Combat Both Opioid Epidemic and COVID-19

Posted by

Icon of newspaper

Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]

Read More ›
Page 2 of 11
1 2 3 4 11